Search results for Johnson And Johnson

<![CDATA[Johnson & Johnson’s Experience Navigating The Commissioner’s National Priority Voucher Program]]>

Johnson & Johnson Joins TrumpRX

Three name-brand diabetes drugs and a blood thinner are now available at a discount on the government platform and J&J’s own website.

Two Paths to Growth: Johnson & Johnson vs AbbVie

Johnson & Johnson: Success In Multiple Myeloma Underpins $25B In Growth By 2030

Johnson & Johnson (JNJ) Q1 2026 Earnings Call Transcript

Johnson & Johnson (JNJ) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

JNJ (NYSE: JNJ) to release Q1 earnings before bell on April 14. Analysts expect $2.67/share & $23.6B revenue. FDA approves TECNIS PureSee lens. Latest Ratings for JNJ Date...

J&J gets naming rights to the Johnson & Johnson Exchange at the New Jersey Innovation Hub, Powered by Portal Inn...

Portal Innovations, in partnership with the New Brunswick Development Corporation (DEVCO) and HELIX, announced May 19 that Johnson & Johnson received naming rights to the Johns...

Why Johnson & Johnson Might Be the Smartest Dividend King to Buy in Today's Market

Johnson & Johnson sells products that are necessities, not just nice-to-haves.

Johnson & Johnson Q2 Earnings Review: Why You Should Be Buying The Stock Today

<![CDATA[Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson &...

Cerenovus Division

Cerenovus Division Anonymous (not verified) Sun, 05/03/2026 - 14:19 field_thread_url https://cafepharma.com/boards/threads/cerenovus-division.685354/...

Johnson & Johnson to Participate in the Bernstein's 42nd Annual Strategic Decisions Conference

Johnson & Johnson (NYSE: JNJ) will present at the Bernstein's 42 nd Annual Strategic Decisions Conference on Wednesday, May 27 th, 2026. Management will participate in a Fires...

Johnson & Johnson teams up with Viz.ai on hematoma detection

Johnson & Johnson is working with artificial intelligence (AI) disease detection and care coordination platform Viz.ai to boost its neurovascular offerings.

Johnson & Johnson Wins Talc Verdict in Oklahoma, Appeal in Pennsylvania

An Oklahoma County District Court jury handed Johnson & Johnson a defense verdict on Wednesday in a talc trial, while a Pennsylvania appeals court affirmed a 2021 win.       

J&J leans on Tremfya, cancer drugs to overcome Stelara losses

A growing multiple myeloma franchise helped the pharmaceutical giant top Wall Street’s expectations and surpass $15 billion in first-quarter drug sales.

3rd Circ. Upholds J&J Injunction Bid Loss In Biosimilar Fight

The Third Circuit on Tuesday ruled that a Johnson & Johnson subsidiary couldn't justify its bid for an order blocking Samsung Bioepis from paving the way for a Cigna unit to la...

Cerenovus Division

Cerenovus Division Anonymous (not verified) Fri, 04/24/2026 - 11:14 field_thread_url https://cafepharma.com/boards/threads/cerenovus-division.685354/...

Why Johnson & Johnson (JNJ) Still Fits a Defensive Growth Case

Johnson & Johnson Benefits are no longer competitive.

Johnson & Johnson Benefits are no longer competitive. Anonymous (not verified) Thu, 04/09/2026 - 20:03 field_thread_url https://cafepharma.com/boards/t...

Laser Photonics Expands into Precision Medical Device Manufacturing with Custom Laser Drilling System Order from Johnson...

$250K Development System Order from Johnson & Johnson Represents Entry into Medical Device Manufacturing; Successful Validation Could Enable Broader Deployment Across Manufactu...

J&J, Tolmar Settle Patent Case Over Antipsychotic Drug

A federal court Wednesday signed off on a consent judgment in a patent case brought by a Johnson & Johnson unit that prevents Tolmar Inc. from selling a generic version of the...

Why We Increased The Position In Johnson & Johnson

Johnson & Johnson Launches Initiative To Support Access To Liquid Biopsy Testing For Non-Small Cell Lung Cancer In T...

Johnson & Johnson has announced a new initiative in the United Arab Emirates aimed at supporting access to liquid biopsy testing for patients diagnosed with metastatic non-smal...